Stockreport

Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR

Equillium, Inc.  (EQ) 
Last equillium, inc. earnings: 3/26 04:07 pm Check Earnings Report
PDF Itolizumab was associated with high clinical response rates at Day 15 and 29?Responders were able to taper steroids by 70% at Day 29 and 99% at Day 169?Itolizumab being [Read more]